BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27188617)

  • 21. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
    Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
    Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis.
    Clancy C; Burke JP; Kalady MF; Coffey JC
    Colorectal Dis; 2013 Dec; 15(12):e711-8. PubMed ID: 24112392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.
    De Renzi G; Gaballo G; Gazzaniga P; Nicolazzo C
    Oncology; 2021; 99(3):135-143. PubMed ID: 33130682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and identification of factors related to
    Lin L; Chen GY; Xu CW; Wang HY; Wu YF; Fang MY
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C191-C198. PubMed ID: 28230016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival.
    Batur S; Vuralli Bakkaloglu D; Kepil N; Erdamar S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):254-260. PubMed ID: 27131021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.
    Loree JM; Pereira AAL; Lam M; Willauer AN; Raghav K; Dasari A; Morris VK; Advani S; Menter DG; Eng C; Shaw K; Broaddus R; Routbort MJ; Liu Y; Morris JS; Luthra R; Meric-Bernstam F; Overman MJ; Maru D; Kopetz S
    Clin Cancer Res; 2018 Mar; 24(5):1062-1072. PubMed ID: 29180604
    [No Abstract]   [Full Text] [Related]  

  • 29. Biomarker correlation network in colorectal carcinoma by tumor anatomic location.
    Nishihara R; Glass K; Mima K; Hamada T; Nowak JA; Qian ZR; Kraft P; Giovannucci EL; Fuchs CS; Chan AT; Quackenbush J; Ogino S; Onnela JP
    BMC Bioinformatics; 2017 Jun; 18(1):304. PubMed ID: 28623901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
    Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A
    Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer.
    Ghanipour L; Jirström K; Sundström M; Glimelius B; Birgisson H
    Eur J Surg Oncol; 2017 Feb; 43(2):311-321. PubMed ID: 27836416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
    Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
    Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes.
    Massalou D; Benizri E; Chevallier A; Duranton-Tanneur V; Pedeutour F; Benchimol D; Béréder JM
    Am J Surg; 2017 Feb; 213(2):377-387. PubMed ID: 27816197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal and colon cancer: Not just a different anatomic site.
    Tamas K; Walenkamp AM; de Vries EG; van Vugt MA; Beets-Tan RG; van Etten B; de Groot DJ; Hospers GA
    Cancer Treat Rev; 2015 Sep; 41(8):671-9. PubMed ID: 26145760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.
    Pilozzi E; Maresca C; Duranti E; Giustiniani MC; Catalanotto C; Lucarelli M; Cogoni C; Ferri M; Ruco L; Zardo G
    Am J Clin Pathol; 2015 Mar; 143(3):374-84. PubMed ID: 25696795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary signet ring cell carcinoma of the colon and rectum.
    Arifi S; Elmesbahi O; Amarti Riffi A
    Bull Cancer; 2015 Oct; 102(10):880-8. PubMed ID: 26412710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future.
    Schiappacasse Cocio GV; Schiappacasse ED
    Cancer Res; 2019 Feb; 79(3):441-444. PubMed ID: 30679175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.